Multiple Lawsuits Against GLP-1 Manufacturers Claim Drugs Carry Risk Of Sudden Vision Loss

Hundreds of consumers have filed lawsuits against Novo Nordisk and Eli Lilly, alleging that GLP-1 weight-loss drugs, including Ozempic, Wegovy, and Mounjaro, cause sudden vision loss. The legal complaints claim these medications are linked to NAION, a rare form of eye stroke that can result in permanent blindness. These multiple lawsuits argue that the manufacturers failed to warn patients about the potential risk of experiencing this severe ocular condition while using the prescribed weight-loss medications.